Editas Medicine, Inc.·4

Sep 8, 4:30 PM ET

Eaton Bruce 4

4 · Editas Medicine, Inc. · Filed Sep 8, 2022

Insider Transaction Report

Form 4
Period: 2022-09-06
Eaton Bruce
EVP, Chief Business Officer
Transactions
  • Sale

    Common Stock

    2022-09-06$15.01/sh101$1,51665,027 total
Footnotes (1)
  • [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2022. The sale does not represent a discretionary trade by the Reporting Person.

Documents

1 file
  • 4
    form4-09082022_040901.xmlPrimary